Sulforaphane and Autoimmune Disease: NRF2, Broccoli Sprouts & Evidence (2026)

Sulforaphane is the quietest heavyweight in autoimmune nutrition. It does not have the trial footprint of vitamin D or the antibody-dropping headlines of selenium. It has something more interesting: a direct molecular on-switch for NRF2, the transcription factor that controls more than 200 antioxidant and detoxification genes, and the same pathway that dimethyl fumarate (Tecfidera) exploits to treat multiple sclerosis and psoriasis.

Autoimmune disease is, at one level, a failure of two linked systems: oxidative stress regulation and immune tolerance. Sulforaphane addresses both. It activates NRF2 to restore redox balance. It suppresses NF-kB to reduce inflammatory cytokine output. It blunts Th17 differentiation, the T-cell subset that drives tissue damage in Hashimoto's, RA, psoriasis, and MS.

The evidence is uneven. The mechanism is rigorous. This article covers what sulforaphane is, how NRF2 works, condition-by-condition evidence, honest dosing, and how to either grow your own broccoli sprouts or buy a supplement that actually contains the active compound.

Medical disclaimer: This article is for educational purposes only and is not medical advice. Sulforaphane is a promising research compound with strong mechanistic rationale but limited autoimmune-specific RCT data. Discuss with your physician before starting any new supplement, especially if you have Hashimoto's (timing around thyroid medication matters) or take prescription drugs.

What Is Sulforaphane?

Sulforaphane is an isothiocyanate, a sulfur-containing compound produced when certain cruciferous vegetables are crushed, chewed, or damaged. It is found in broccoli, cauliflower, kale, brussels sprouts, cabbage, bok choy, and arugula. Broccoli and broccoli sprouts contain the highest concentrations.

The compound does not exist preformed in the intact plant. What the plant stores is a precursor called glucoraphanin, a glucosinolate that sits inert in cell vacuoles. A separate enzyme, myrosinase, is compartmentalized elsewhere in the plant. When the cell wall is broken, the two meet. Myrosinase hydrolyzes glucoraphanin, and sulforaphane is born.

This chemistry matters for dosing. If you cook broccoli until myrosinase is denatured (the enzyme is heat-sensitive above 140 degrees F), you lose most sulforaphane production. If you swallow whole broccoli sprouts without chewing, you get less conversion than if you chew thoroughly. If you buy a supplement that lists glucoraphanin but no myrosinase, you depend on your gut bacteria to do the conversion, and results vary widely between individuals.

Broccoli Sprouts: 20-50x the Precursor

Jed Fahey and Paul Talalay at Johns Hopkins published the foundational paper in PNAS (1997) that established broccoli sprouts as a sulforaphane superfood. Their analysis showed that 3-day-old broccoli sprouts contained 20 to 50 times more glucoraphanin by weight than mature broccoli. The precursor concentration peaks at days 3-7 of germination and declines as the plant matures.

This finding created a practical therapeutic opportunity. A gram of dried broccoli sprout powder or 100-200 grams of fresh sprouts can deliver sulforaphane equivalents that would require multiple pounds of mature broccoli. The Fahey-Talalay paper is the reason the supplement industry for standardized broccoli products exists at all.

The NRF2 Pathway: Why Autoimmune Patients Should Care

NRF2 (Nuclear factor erythroid 2-related factor 2) is a transcription factor that sits at the top of the cell's antioxidant and detoxification machinery. When activated, NRF2 translocates to the nucleus and binds to antioxidant response elements (ARE) in DNA, turning on more than 200 genes.

The genes it activates are the ones you want working when your tissue is under immune attack: heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1), glutamate-cysteine ligase catalytic subunit (GCLC) — the rate-limiting enzyme for glutathione synthesis, thioredoxin, superoxide dismutase, and a long list of phase II detoxification enzymes.

How NRF2 Gets Switched On

Under normal conditions, NRF2 is bound in the cytoplasm by a protein called Keap1, which tags it for degradation. Keap1 contains reactive cysteine residues. When an electrophile like sulforaphane binds those cysteines, Keap1 can no longer degrade NRF2. NRF2 accumulates, enters the nucleus, and switches on its gene program.

Sulforaphane is one of the most potent known natural NRF2 activators. Its mechanism is covalent modification of Keap1 cysteines. Unlike antioxidants that quench free radicals one at a time, NRF2 activation is catalytic: one sulforaphane molecule triggers transcription of hundreds of antioxidant enzymes that each process millions of reactive species.

Why NRF2 Matters in Autoimmune Disease

In autoimmune patients, NRF2 is often underactive. Baseline expression is lower. Responsiveness to stress is blunted. Glutathione levels run low. Oxidative damage accumulates. The immune system, exposed to oxidized self-proteins it no longer recognizes as "self," mounts attacks.

Restoring NRF2 activity does three things that directly touch autoimmune pathology:

1. Reduces oxidative damage to self-tissue, meaning fewer neo-antigens for the immune system to react against
2. Suppresses NF-kB signaling, the parallel pathway that drives IL-6, TNF-alpha, and IL-1beta output
3. Biases T-cell differentiation away from inflammatory Th17 and toward regulatory Treg phenotypes

The pharmaceutical world has already validated this target. Dimethyl fumarate (Tecfidera), approved by the FDA in 2013 for relapsing multiple sclerosis and later for psoriasis, is an NRF2 activator. It is Grade A evidence that activating this pathway changes autoimmune disease outcomes in humans. Sulforaphane hits the same endpoint through a different entry point.

Sulforaphane by Autoimmune Condition

Most sulforaphane-autoimmune data is preclinical or small pilot. The exception is the MS-psoriasis pathway validation through dimethyl fumarate. Here is where the evidence stands, condition by condition.

Hashimoto's Thyroiditis [Grade C]

Xu et al. published a small pilot evaluating broccoli sprout extract in Hashimoto's patients. The trial reported substantial TPO antibody reductions (in the 70-90% range) in the treatment group over 8-12 weeks. The mechanism fit: NRF2 activation reduces thyroid oxidative stress, sulforaphane suppresses NF-kB in thyrocytes, and glutathione replenishment protects thyroid tissue from H2O2 generated during hormone synthesis.

The honest caveat: the sample size was small. Large RCTs replicating these results do not yet exist. Treat the Hashimoto's data as promising rather than definitive. For a complete Hashimoto's protocol with interventions graded across evidence tiers, see the Hashimoto's natural treatment pillar and the supplements for Hashimoto's guide.

Sulforaphane complements selenium, which has Grade A evidence for TPO antibody reduction through a different mechanism (glutathione peroxidase cofactor). The two attack oxidative stress at different control points.

Multiple Sclerosis [Grade A for NRF2 target, Grade C for sulforaphane specifically]

The NRF2 pathway in MS is not speculative. Dimethyl fumarate (Tecfidera) is a front-line oral disease-modifying therapy with multiple large Phase 3 RCTs showing reduced relapse rates and reduced MRI lesion activity. The drug works by activating NRF2, depleting glutathione transiently in T cells, inducing immune cell apoptosis, and shifting the inflammatory balance.

Preclinical sulforaphane data in experimental autoimmune encephalomyelitis (EAE), the mouse model of MS, shows reduced disease severity, reduced demyelination, and reduced spinal cord infiltration by pathogenic T cells. Human trials of sulforaphane specifically for MS are limited. The mechanistic extrapolation from dimethyl fumarate is strong. The direct sulforaphane evidence in MS patients is not.

Rheumatoid Arthritis [Grade C]

Animal models of collagen-induced arthritis show reduced joint inflammation, reduced pannus formation, and reduced cartilage destruction with sulforaphane treatment. The mechanism involves suppression of Th17 cells and IL-17 cytokine output, plus direct NF-kB inhibition in synovial fibroblasts.

Small human studies have reported reductions in inflammatory biomarkers (CRP, IL-6) with sulforaphane supplementation in RA patients, though large RCTs are missing. For a condition where curcumin has Grade B evidence, sulforaphane is a reasonable additional anti-inflammatory with a distinct mechanism.

Lupus (SLE) [Grade C]

Preclinical lupus models (MRL/lpr mice) show reduced kidney damage and reduced autoantibody titers with sulforaphane treatment. Mechanistically, lupus is characterized by profound glutathione depletion and NRF2 dysregulation, and the clinical precedent of NAC supplementation in lupus reinforces the importance of glutathione restoration. Sulforaphane addresses glutathione synthesis upstream by inducing GCLC, the rate-limiting enzyme.

Human lupus-specific trials of sulforaphane are lacking. The mechanistic case is strong; the clinical validation is not.

Psoriasis [Grade B topical, Grade C oral]

Topical sulforaphane formulations have shown plaque severity reduction in small clinical studies. The connection to systemic psoriasis therapy via dimethyl fumarate (approved in Europe for psoriasis before its MS indication) makes NRF2 a validated target. For dietary and lifestyle strategies in psoriasis, see the psoriasis diet and natural treatment guide.

Inflammatory Bowel Disease [Grade C]

Murine colitis models (DSS-induced, TNBS-induced) consistently show reduced inflammation with sulforaphane. The gut-specific case is interesting because sulforaphane also has broad antimicrobial activity against H. pylori and other gram-negative bacteria relevant to gut dysbiosis. Human IBD data is limited to small pilots. Larger trials are needed before oral sulforaphane can be recommended with confidence for Crohn's or UC. Gut healing in autoimmune disease requires a multi-pronged approach; see the leaky gut autoimmune protocol.

Type 1 Diabetes [Grade B]

Yagishita et al. (2019) demonstrated that sulforaphane improved fasting glucose and reduced oxidative stress markers in patients with type 2 diabetes. Axelsson et al. (Science Translational Medicine, 2017) published a landmark paper showing that sulforaphane combined with metformin produced significant improvements in HbA1c in type 2 diabetic patients, with the sulforaphane component acting through NRF2-mediated suppression of hepatic glucose production.

Type 1 diabetes data is thinner. The mechanism (NRF2-mediated beta cell protection from oxidative stress) is plausible, and preclinical models support it, but large T1D-specific RCTs are not yet published.

Helicobacter pylori and Gut Health

Outside the autoimmune conversation, sulforaphane has documented activity against H. pylori, a bacterium causally linked to gastric ulcers and gastric cancer. Yanaka et al. demonstrated reduced H. pylori colonization in humans consuming broccoli sprouts. This is relevant because H. pylori infection is a common co-factor in autoimmune thyroid disease (through molecular mimicry) and may contribute to autoimmune gastritis.

The Dimethyl Fumarate Connection

This is the keystone that makes sulforaphane a credible autoimmune intervention rather than a wellness supplement.

Dimethyl fumarate (Tecfidera, developed from Fumaderm which has been used in Germany for psoriasis since 1994) is an FDA-approved NRF2 activator. The DEFINE and CONFIRM trials (New England Journal of Medicine, 2012) randomized over 2,500 patients with relapsing-remitting MS and showed:

• 53% reduction in annualized relapse rate versus placebo
• Significant reduction in new or enlarging T2 MRI lesions
• Reduced disability progression over 2 years

The mechanism is NRF2 activation plus Nrf2-independent glutathione depletion in activated T cells. The drug is Grade A evidence that pharmacological NRF2 activation modifies autoimmune disease course.

Sulforaphane activates NRF2 through a different covalent mechanism (Keap1 cysteine modification vs fumarate's Michael addition). The downstream gene program overlaps substantially. What this means practically: the target is proven. Sulforaphane is a natural compound that engages the same validated target, with a better safety profile than dimethyl fumarate (which carries risks of lymphopenia and progressive multifocal leukoencephalopathy) but weaker direct clinical evidence.

You should not substitute broccoli sprouts for prescribed dimethyl fumarate if you have MS. You can reasonably use sulforaphane as an adjunct or as a mechanistically-aligned intervention in autoimmune conditions where no NRF2 activator is yet approved.

Dosing: Getting Therapeutic Sulforaphane

The gap between "eating broccoli" and "getting a therapeutic sulforaphane dose" is larger than most people assume. The numbers below reflect what published trials have used.

Fresh Broccoli Sprouts

100 to 200 grams of fresh 3-7 day old broccoli sprouts per day delivers approximately 20-40 mg sulforaphane when chewed thoroughly (assuming adequate endogenous myrosinase from the sprouts themselves). Use organic seed to avoid pesticide concentration, and harvest between days 3-7 of germination when glucoraphanin content peaks.

Chew until the sprouts are a paste. Swallowing whole sprouts reduces myrosinase-glucoraphanin contact and cuts sulforaphane yield substantially. Some people take sprouts with a small amount of daikon radish or mustard powder, both of which contain supplemental myrosinase.

Supplements

Prostaphane — French prescription product, 10 mg stabilized sulforaphane per capsule. Typical dosing is 1-4 capsules daily (10-40 mg sulforaphane). The active compound is stabilized in the formulation, so myrosinase is not required for conversion. This is the product used in several European clinical trials.

Avmacol — US-available, contains standardized glucoraphanin plus active myrosinase from broccoli seed and sprout extract. Typical dosing is 2-4 tablets daily, delivering approximately 15-30 mg sulforaphane equivalents. Used in multiple Johns Hopkins clinical trials.

Thorne Sulforaphane Glucosinolate — standardized glucoraphanin. Relies on gut bacteria for conversion, so results are more variable. Pair with a separate myrosinase source (daikon, mustard powder) or chew it with a raw cruciferous vegetable.

Avoid products that list only glucoraphanin with no myrosinase source, especially if you have reduced gut diversity from antibiotics, PPIs, or an elimination diet. Without myrosinase, the tablet may pass through largely unconverted.

Typical Therapeutic Range

Timing and Absorption

• Take with a meal to slow absorption and improve tolerability.
• Twice daily (morning and evening) if using the higher end of the range — sulforaphane's plasma half-life is roughly 2-3 hours, so split dosing maintains NRF2 activation over a longer window.
• Heat destroys myrosinase. Do not steam, stir-fry, or cook broccoli sprouts if you are relying on their own myrosinase. Add raw sprouts to a cooled dish, or use a supplement with stabilized sulforaphane.
• Separate from levothyroxine by 2 hours if you take thyroid medication. This is a precaution; there is no documented direct interaction, but cruciferous compounds can theoretically affect thyroid hormone absorption and metabolism.

Growing Your Own Broccoli Sprouts

Therapeutic-dose sprouts from a grocery store cost roughly $5-8 for a few days of supply. Growing them at home costs cents per serving and guarantees freshness. The full cycle is 4-5 days.

Equipment

• One quart mason jar
• Sprouting lid (mesh) or a square of cheesecloth with a rubber band
• 2 tablespoons organic broccoli sprouting seeds (choose seeds specifically marketed for sprouting; standard garden seeds may be treated)

Protocol

Day 0 (evening). Rinse 2 tablespoons of seeds thoroughly. Place in the mason jar, cover with 2 cups of filtered water, and soak overnight (8-12 hours). Cover with the mesh lid.

Day 1 (morning). Drain through the mesh lid. Rinse seeds with cool water. Drain completely and set the jar at a 45-degree angle in a dark cupboard so air circulates and excess water drains. Rinse and drain again in the evening.

Days 2-4. Continue rinsing and draining morning and evening. Keep the jar in a dark location. Sprouts will start to appear on day 2. By day 3-4, they will fill the jar and develop the first green cotyledons.

Day 4-5 (harvest). Move the jar to indirect light for 4-8 hours to let the sprouts green up (this increases sulforaphane yield). Rinse one more time, drain thoroughly, and transfer to an airtight container in the refrigerator.

Food Safety

Sprouts have been linked to outbreaks of E. coli and Salmonella in commercial production. Home growing is safer if you follow two rules: use seeds from a reputable sprouting-seed supplier (they test seed lots), and rinse thoroughly before eating. Discard any batch that smells sour or develops visible mold. Eat within 5-7 days of harvest.

Safety, Side Effects, and Who Should Be Cautious

Sulforaphane has a strong safety profile at dietary and standard supplemental doses. Human trials at 100 umol/day (approximately 17 mg sulforaphane) for 12 weeks reported no serious adverse events. The most common side effects are mild.

Common and usually mild:

• Sulfur-smelling flatulence, especially during the first 1-2 weeks
• Mild GI upset with high doses, usually resolves with food and split dosing
• Increased urine odor (harmless, reflects isothiocyanate metabolism)

Potential concerns in specific populations:

• Active hypothyroidism with low iodine status. Cruciferous vegetables contain goitrogens (thiocyanates, isothiocyanates) that can theoretically interfere with iodine uptake at high intake. In iodine-replete individuals, this effect is clinically negligible. If you are iodine-deficient, correct iodine status first, or discuss with your physician.
• Thyroid medication timing. Separate broccoli sprout supplements from levothyroxine by 2 hours as a precaution.
• Sulfur sensitivity. Some people (particularly those with CBS gene variants or sulfur-processing issues) may experience headaches, fatigue, or GI symptoms. Start at a low dose (10 mg) and titrate up.
• Cruciferous vegetable intolerance. Rare but real. If you get bloating or histamine-type reactions from broccoli or cabbage, proceed cautiously.
• Pregnancy and breastfeeding. Food amounts are safe. Supplemental doses are not well studied. Discuss with your obstetrician.
• Warfarin. Cruciferous vegetables contain vitamin K1. High intake can affect warfarin dosing. This is a consumption-consistency issue, not a prohibition.

The Thyroid Goitrogen Myth

A persistent myth claims that Hashimoto's patients must avoid cruciferous vegetables. The actual evidence tells a different story. The Xu Hashimoto's pilot used broccoli sprout extract and reported TPO antibody reduction, not worsening. Population studies have not found cruciferous intake associated with thyroid dysfunction in iodine-replete individuals. The NRF2 and anti-inflammatory effects of sulforaphane appear to outweigh any theoretical goitrogenic concern.

If you have concerns, check your iodine status with a urinary iodine test, ensure adequate intake (150 mcg/day for adults, 220 mcg in pregnancy), and proceed. For broader context on Hashimoto's nutrition, see the Hashimoto's lab targets guide and vitamin D and thyroid.

Supplements to Stack With Sulforaphane

Sulforaphane rarely works in isolation for autoimmune disease. It fits well within a broader protocol that addresses the core drivers of immune dysregulation.

Vitamin D3 + K2. The VITAL trial demonstrated 22% reduction in autoimmune disease incidence with 2,000 IU/day vitamin D3. Vitamin D and NRF2 share regulatory overlap, and vitamin D sufficiency (40-60 ng/mL) is a precondition for optimal immune tolerance. See vitamin D and thyroid and the best supplements for autoimmune disease guide.

NAC (N-acetylcysteine). NAC supplies cysteine, the rate-limiting amino acid for glutathione synthesis. Sulforaphane induces the enzyme (GCLC) that uses cysteine to make glutathione. Pairing them addresses supply and synthesis capacity together. Typical dose: 600-1,200 mg/day.

Omega-3 fatty acids (EPA + DHA). 2-3 g/day EPA+DHA provides independent anti-inflammatory effects through specialized pro-resolving mediators (resolvins, protectins, maresins). Mechanism is distinct from NRF2 activation, so the effects are additive.

Selenium (for Hashimoto's specifically). 200 mcg/day selenomethionine. Grade A evidence for TPO antibody reduction. The combination of selenium (glutathione peroxidase cofactor) and sulforaphane (glutathione synthesis inducer) covers both sides of the glutathione antioxidant system. See selenium for Hashimoto's.

Curcumin. For inflammatory autoimmune conditions (RA, IBD, psoriasis), curcumin (500-1,000 mg with piperine, or a high-absorption form like Meriva) suppresses NF-kB through a parallel pathway to sulforaphane. See curcumin for rheumatoid arthritis.

AIP-style elimination diet or Mediterranean diet. Supplementation works better when dietary drivers of inflammation are removed. See the autoimmune diet comparison.

Timeline: What to Expect

Hours to days. NRF2 activation begins within hours of the first dose. Downstream enzyme induction (HO-1, NQO1, glutathione) peaks over 1-3 days.

Weeks 1-2. Possible transient sulfur-smelling flatulence. Some patients report improved energy or reduced brain fog within this window; others notice nothing yet.

Weeks 4-8. Inflammatory biomarkers (CRP, IL-6) may begin to trend down if elevated at baseline. Patients with oxidative-stress-driven symptoms (fatigue, skin issues, joint aches) often report incremental improvements here.

Weeks 8-12. The published Hashimoto's and diabetes trials evaluated outcomes at this point. If sulforaphane is going to move antibody titers or metabolic markers, you should see evidence by 12 weeks. Retest relevant labs (TPO antibodies, CRP, HbA1c, whatever applies to your condition) at 3 months.

Months 3-6. Maintenance phase. Sulforaphane can be used long-term at dietary-to-moderate supplemental doses. Consider rotating cruciferous sources (sprouts, mature broccoli, kale, arugula, bok choy) for variety.

If you see no change in symptoms or biomarkers after a 12-week trial, sulforaphane may not be the leverage point for your case. NRF2 dysfunction is one of several autoimmune drivers, and some patients respond more to other interventions (gut healing, leaky gut protocol, stress modulation, LDN, peptides).

Evidence Summary

Frequently Asked Questions

Does sulforaphane help autoimmune disease?

Sulforaphane activates the NRF2 pathway, which controls the body's master antioxidant and detoxification response. NRF2 dysregulation is documented in most autoimmune conditions. Dimethyl fumarate (Tecfidera), an FDA-approved NRF2 activator, has Grade A evidence for multiple sclerosis and psoriasis, validating the target. Sulforaphane is the most potent natural NRF2 activator identified, though most autoimmune-specific data is preclinical or small pilot. The Xu Hashimoto's pilot reported significant TPO antibody reductions, but the sample was small and results need replication.

How many broccoli sprouts do I need to eat?

A therapeutic daily dose is roughly 100-200 grams of fresh 3-7 day old broccoli sprouts, or a standardized supplement delivering 20-40 mg sulforaphane (equivalent to 60-120 mg glucoraphanin plus active myrosinase). Broccoli sprouts contain 20-50 times more glucoraphanin (the sulforaphane precursor) than mature broccoli. Chew them thoroughly to activate myrosinase, the enzyme that converts glucoraphanin to sulforaphane.

What is the best sulforaphane supplement?

The three clinically credible options are Prostaphane (10 mg stable sulforaphane, prescription in France), Avmacol (standardized glucoraphanin plus active myrosinase from broccoli seed and sprout), and Thorne Sulforaphane Glucosinolate. Avoid products that list glucoraphanin alone without a myrosinase source, because without the enzyme, absorption depends entirely on your gut bacteria and may be minimal.

Are broccoli sprouts bad for the thyroid?

At normal dietary or therapeutic doses in iodine-replete individuals, no. The goitrogenic concern with cruciferous vegetables is largely theoretical when iodine status is adequate. The Xu et al. Hashimoto's pilot reported TPO antibody reduction with broccoli sprout extract, suggesting the NRF2 and anti-inflammatory effects outweigh any goitrogenic concern. Ensure adequate iodine from seafood, seaweed, or a multivitamin. Separate broccoli sprout supplements from levothyroxine by 2 hours.

How long does it take sulforaphane to work?

NRF2 activation occurs within hours of a single dose, with downstream antioxidant enzymes (HO-1, NQO1, glutathione) increasing over 1-3 days. Clinically meaningful changes in inflammatory markers or autoimmune antibodies require 8-12 weeks of consistent daily use. The Hashimoto's pilot ran 12 weeks. The diabetes trials by Axelsson and Yagishita ran 12 weeks. Plan for a 3-month trial before judging effect.

Can I grow my own broccoli sprouts?

Yes, and it is the cheapest way to dose sulforaphane therapeutically. Rinse 2 tablespoons of organic broccoli sprouting seeds, soak overnight in a mason jar, drain and rinse twice daily, and harvest on day 4-5 when sprouts are 1-2 inches long. Eat within a few days. Food safety note: rinse thoroughly and consume fresh, because sprouts have been linked to E. coli and Salmonella outbreaks when grown in unclean conditions.

Is sulforaphane safe long-term?

Sulforaphane has a strong safety profile at dietary and standard supplemental doses. Human trials at 100 umol/day (approximately 17 mg sulforaphane) for 12 weeks showed no clinically significant adverse events. The most common issues are mild gastrointestinal upset and sulfur-smelling flatulence. People with cruciferous sensitivity, sulfur intolerance, or active hypothyroidism with low iodine should discuss use with their physician first.

Where to Start

Sulforaphane is a reasonable addition to an autoimmune protocol if you have established the foundations: vitamin D sufficiency, omega-3 intake, an anti-inflammatory diet approach, and gut healing work if permeability is a driver. It is not a first-line intervention. It is a mechanistically sound layer on top of a well-built base.

For most adults with an autoimmune condition and no major contraindications:

1. Choose your delivery: fresh broccoli sprouts (100-200 g/day, chewed thoroughly) or a standardized supplement (Prostaphane, Avmacol, or Thorne SG with a myrosinase source).
2. Start low, titrate up: begin with the equivalent of 10 mg sulforaphane daily for the first week, increase to 20-40 mg if tolerated.
3. Take with a meal. Split into two doses if using the higher end of the range.
4. Separate from levothyroxine by 2 hours if applicable.
5. Run a 12-week trial. Retest relevant biomarkers (TPO antibodies, CRP, HbA1c, whichever applies) at baseline and at 3 months.
6. Continue long-term if you see improvement; discontinue and reallocate the budget elsewhere if you do not.

Your protocol should match your specific condition, severity, lab values, and current medications. Sulforaphane fits differently for Hashimoto's with elevated TPO versus RA with active joint inflammation versus MS on dimethyl fumarate.

Take the free 3-minute AutoimmuneFinder quiz to build a personalized, evidence-graded protocol matched to your specific condition, severity, and current treatment plan.

This article is for educational purposes only and does not constitute medical advice. Autoimmune diseases are serious chronic conditions requiring ongoing medical supervision. Do not start, stop, or change any supplement or medication without consulting your physician or specialist. All dosage recommendations should be discussed with your healthcare provider before implementation.